Page last updated: 2024-09-05

paromomycin and Infections, Coronavirus

paromomycin has been researched along with Infections, Coronavirus in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Afzal, MS; Mateen, RM; Saleem, M; Tariq, A1
Baddal, B; Gülcan, HO; Teralı, K1

Other Studies

2 other study(ies) available for paromomycin and Infections, Coronavirus

ArticleYear
Paromomycin: A potential dual targeted drug effectively inhibits both spike (S1) and main protease of COVID-19.
    International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2020, Volume: 98

    Topics: Betacoronavirus; Computer Simulation; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Repositioning; Humans; Molecular Docking Simulation; Pandemics; Paromomycin; Peptide Hydrolases; Pneumonia, Viral; Protease Inhibitors; Protein Binding; SARS-CoV-2; Spike Glycoprotein, Coronavirus

2020
Prioritizing potential ACE2 inhibitors in the COVID-19 pandemic: Insights from a molecular mechanics-assisted structure-based virtual screening experiment.
    Journal of molecular graphics & modelling, 2020, Volume: 100

    Topics: Amino Acid Motifs; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Antiviral Agents; Betacoronavirus; Carbazoles; Catalytic Domain; Coronavirus Infections; COVID-19; Drug Repositioning; Dyphylline; Host-Pathogen Interactions; Humans; Hydroxamic Acids; Ligands; Molecular Docking Simulation; Pandemics; Paromomycin; Pemetrexed; Peptidyl-Dipeptidase A; Pneumonia, Viral; Protein Binding; Protein Interaction Domains and Motifs; Protein Structure, Secondary; SARS-CoV-2; Small Molecule Libraries; Structure-Activity Relationship; Thermodynamics

2020